this study was designed to test the hypothesis that in patients with elevated plasma low-density lipoprotein ( ldl ) apolipoprotein-apob , chylomicron remnant clearance can be modulated by therapy with a hepatic hydroxymethyl glutaryl coenzyme a reductase inhibitor .
C0003591
apolipoprotein
C0003593
apob